PHAR (PHARMING GROUP NV) is held by 4 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($191,177), CITADEL ADVISORS LLC ($169,545), BNP PARIBAS FINANCIAL MARKETS ($6,656). Net institutional sentiment: Bearish.
See how PHAR's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer